The PhINEST Study - Pharyngeal ICU Novel Electrical Stimulation Therapy
NCT: NCT03840395 · TERMINATED
Brief Summary
This is a prospective, multi-site, randomised, sham-controlled, single-blind (outcome assessor-blinded) study designed to assess the effects of Pharyngeal Electrical Stimulation (PES) (using Phagenyx®) for the treatment of oropharyngeal dysphagia after invasive mechanical ventilation (of any duration) by means of naso or oro-tracheal tube in critically ill intensive care unit (ICU) patients.
Frequently Asked Questions
What is The PhINEST Study - Pharyngeal ICU Novel Electrical Stimulation Therapy?
The PhINEST Study - Pharyngeal ICU Novel Electrical Stimulation Therapy is a clinical trial registered under NCT03840395. Current status: TERMINATED.
What is the status of NCT03840395?
The current status of NCT03840395 (The PhINEST Study - Pharyngeal ICU Novel Electrical Stimulation Therapy) is: TERMINATED.
When did The PhINEST Study - Pharyngeal ICU Novel Electrical Stimulation Therapy start?
The PhINEST Study - Pharyngeal ICU Novel Electrical Stimulation Therapy started on 2019-06-17.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.